Pharmafile Logo
Pharmafocus logo
Advanced Search

conjugate

Showing 2 posts of 2 posts found.

Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015
Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

News

Lilly teams up with ImmunoGen on antibody-drug conjugates

December 21, 2011
ADC, Cancer, Immunogen, T-DM1, conjugate, lilly, oncology

ImmunoGen has signed a new collaboration with Eli Lilly to develop antibody-drug conjugate for cancer treatments.Lilly will pay an upfront …

News
The Gateway to Local Adoption Series

Latest content

Capital Dynamics invests €14m in Italian community healthcare platform CareHub

October 30, 2026

Medtronic secures CE Mark for new cardiac pacing portfolio

October 30, 2026

Dermatology leader Doncker is new Onicor CEO

October 29, 2026

East London pharmacies pilot cholesterol-lowering injections to cut waiting times

October 29, 2026

Weber is new CMO at Sensorion

October 28, 2026